Clinical Trial: Oral Colloidal Silicon Dioxide Added to Routine Treatment for Acute Urticaria in the Emergency Department

U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07866092) titled 'Oral Colloidal Silicon Dioxide Added to Routine Treatment for Acute Urticaria in the Emergency Department' on Oct. 05.

Brief Summary: The goal of this observational study is to learn whether adding a single oral dose of colloidal silicon dioxide, an enterosorbent, to routine emergency department treatment is associated with faster early improvement in adults with acute urticaria. The main question it aims to answer is: Is the change in urticaria activity over the first 2 hours different in patients who receive colloidal silicon dioxide in addition to intravenous pheniramine compared with patients who receive intravenous pheniramine a...